Anixa Biosciences, Inc.
ANIXBiotechnology
$3.12−5.45%As of Oct 30vs prior close
- Market cap
- $108.5M
- P/E (TTM)
- –
- From 52W high
- −40.23%
- EPS (LTM)
- -$0.31
- Revenue (YE24)
- $210K
- Dividend yield
- 0.00%
Nomior Score
32
Steady ProfileSpeculativeBottom 17% of the scored universe
Growth—
Quality38
Value—
Momentum20
Resilience42
Growth
−4.36%revenue a year over 8 fiscal years
YE16 $300KYE24 $210K
Connections
Revenue to profitYE24
The operating loss was 6586% of revenue, wider by 1343 pts on a year.
Who owns it
1fund